An OCSCC cohort more than twice the size of the TCGA cohort allowed us to find additional cancer driver genes that are frequently affected in CNA-quiet OCSCC, notably PIK3CA, RAC1, and TERT, besides the previously established HRAS and CASP8. This evidence concerns the gene HRAS and cancer.